60 related articles for article (PubMed ID: 24477173)
1. Fluorescence in situ hybridization testing for the diagnosis of high-grade cervical abnormalities: a systematic review.
Earley A; Lamont JL; Dahabreh IJ; Cowan J; Feldman S; Uhlig K
J Low Genit Tract Dis; 2014 Jul; 18(3):218-27. PubMed ID: 24477173
[TBL] [Abstract][Full Text] [Related]
2. Prediction of outcome in patients with low-grade squamous intraepithelial lesions by fluorescence in situ hybridization analysis of human papillomavirus, TERC, and MYC.
Obermann EC; Savic Prince S; Barascud A; Grilli B; Herzog M; Kaup D; Cathomas G; Frey Tirri B; Zlobec I; Wight E; Bubendorf L
Cancer Cytopathol; 2013 Aug; 121(8):423-31. PubMed ID: 23408758
[TBL] [Abstract][Full Text] [Related]
3. Human telomerase RNA gene amplification detection increases the specificity of cervical intraepithelial neoplasia screening.
Zheng L; Liu AL; Qi T; Wang Q; Cai Z; Su YJ; Hu YW; Liu GB; Wei LH
Int J Gynecol Cancer; 2010 Aug; 20(6):912-7. PubMed ID: 20683395
[TBL] [Abstract][Full Text] [Related]
4. Genomic amplification patterns of human telomerase RNA gene and C-MYC in liquid-based cytological specimens used for the detection of high-grade cervical intraepithelial neoplasia.
Chen S; Yang Z; Zhang Y; Qiao Y; Cui B; Zhang Y; Kong B
Diagn Pathol; 2012 Apr; 7():40. PubMed ID: 22500694
[TBL] [Abstract][Full Text] [Related]
5. [Clinical application of telomerase RNA component gene amplification assay in cervical lesions.].
Jiang J; Wei LH; Wu RF; Zhang G; Wulan N; Li JR; Li YB; Tu Z; Zhou YQ; Zhao Y; Chen Z
Zhonghua Fu Chan Ke Za Zhi; 2009 Dec; 44(12):883-6. PubMed ID: 20193412
[TBL] [Abstract][Full Text] [Related]
6. Genomic amplification of the human telomerase RNA gene for differential diagnosis of cervical disorders.
Tu Z; Zhang A; Wu R; Jiang J; Li Y; Wulan N; Li J; Zhang Y; Li Y; Chen Z; Wei L
Cancer Genet Cytogenet; 2009 May; 191(1):10-6. PubMed ID: 19389503
[TBL] [Abstract][Full Text] [Related]
7. Genomic integration of oncogenic HPV and gain of the human telomerase gene TERC at 3q26 are strongly associated events in the progression of uterine cervical dysplasia to invasive cancer.
Hopman AH; Theelen W; Hommelberg PP; Kamps MA; Herrington CS; Morrison LE; Speel EJ; Smedts F; Ramaekers FC
J Pathol; 2006 Dec; 210(4):412-9. PubMed ID: 17054308
[TBL] [Abstract][Full Text] [Related]
8. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer.
Arbyn M; Ronco G; Anttila A; Meijer CJ; Poljak M; Ogilvie G; Koliopoulos G; Naucler P; Sankaranarayanan R; Peto J
Vaccine; 2012 Nov; 30 Suppl 5():F88-99. PubMed ID: 23199969
[TBL] [Abstract][Full Text] [Related]
9. Significance of human telomerase RNA gene amplification detection for cervical cancer screening.
Chen SM; Lin W; Liu X; Zhang YZ
Asian Pac J Cancer Prev; 2012; 13(5):2063-8. PubMed ID: 22901172
[TBL] [Abstract][Full Text] [Related]
10. Detection of TERC amplification in cervical epithelial cells for the diagnosis of high-grade cervical lesions and invasive cancer: a multicenter study in China.
Jiang J; Wei LH; Li YL; Wu RF; Xie X; Feng YJ; Zhang G; Zhao C; Zhao Y; Chen Z
J Mol Diagn; 2010 Nov; 12(6):808-17. PubMed ID: 20864639
[TBL] [Abstract][Full Text] [Related]
11. Increase in viral load, viral integration, and gain of telomerase genes during uterine cervical carcinogenesis can be simultaneously assessed by the HPV 16/18 MLPA-assay.
Theelen W; Speel EJ; Herfs M; Reijans M; Simons G; Meulemans EV; Baldewijns MM; Ramaekers FC; Somja J; Delvenne P; Hopman AH
Am J Pathol; 2010 Oct; 177(4):2022-33. PubMed ID: 20813962
[TBL] [Abstract][Full Text] [Related]
12. Cost effectiveness of human papillomavirus-16/18 genotyping in cervical cancer screening.
Huh WK; Williams E; Huang J; Bramley T; Poulios N
Appl Health Econ Health Policy; 2015 Feb; 13(1):95-107. PubMed ID: 25385310
[TBL] [Abstract][Full Text] [Related]
13. Screening of TERC gene amplification as an additional genetic diagnostic test in detection of cervical preneoplastic lesions.
Kokalj-Vokac N; Kodric T; Erjavec-Skerget A; Zagorac A; Takac I
Cancer Genet Cytogenet; 2009 Nov; 195(1):19-22. PubMed ID: 19837263
[TBL] [Abstract][Full Text] [Related]
14. Detection of HPV16 and 18 by in situ hybridization in precancerous and cancerous lesions of cervix.
Choudhury M; Singh S
Indian J Pathol Microbiol; 2006 Jul; 49(3):345-7. PubMed ID: 17001881
[TBL] [Abstract][Full Text] [Related]
15. Detection of hTERC and c-MYC genes in cervical epithelial exfoliated cells for cervical cancer screening.
Li T; Tang L; Bian D; Jia Y; Huang X; Zhang X
Int J Mol Med; 2014 May; 33(5):1289-97. PubMed ID: 24626956
[TBL] [Abstract][Full Text] [Related]
16. Human telomerase RNA gene (TERC) gain and polysomy of chromosome 3 in cervicovaginal liquid-based pap preparations: a fluorescence in situ hybridization study.
Sui W; Ou M; Chen J; Yu J; Zhang Y; Lan H; Huang H; Dai Y
Eur J Gynaecol Oncol; 2010; 31(4):375-9. PubMed ID: 20882876
[TBL] [Abstract][Full Text] [Related]
17. High-risk human papillomavirus detection in women with low-grade squamous intraepithelial lesions or higher-grade cytology using the Cervista HPV HR test.
Gold MA; Thomas MA; Huh WK; Sarto GE; Day SP
J Low Genit Tract Dis; 2013 Jan; 17(1):51-7. PubMed ID: 22885641
[TBL] [Abstract][Full Text] [Related]
18. Risks of CIN 2+, CIN 3+, and Cancer by Cytology and Human Papillomavirus Status: The Foundation of Risk-Based Cervical Screening Guidelines.
Demarco M; Lorey TS; Fetterman B; Cheung LC; Guido RS; Wentzensen N; Kinney WK; Poitras NE; Befano B; Castle PE; Schiffman M
J Low Genit Tract Dis; 2017 Oct; 21(4):261-267. PubMed ID: 28953116
[TBL] [Abstract][Full Text] [Related]
19. [Detection of TERC gene amplification by fluorescence in-situ hybridization in cervical intraepithelial lesions].
YUAN YL; HE CN; XU MT; XU CQ; SUN YN; ZHAO HF; CHEN C
Zhonghua Bing Li Xue Za Zhi; 2011 Mar; 40(3):182-6. PubMed ID: 21575390
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
